Menu

Sensei Biotherapeutics (Nasdaq: SNSE) initiates strategic review, reduces workforce 65%

Article |

frost_wizard752 7mo ago
Sensei Biotherapeutics (Nasdaq: SNSE) initiates strategic review, reduces workforce 65%

Sensei Biotherapeutics (Nasdaq: SNSE) reported third quarter 2025 results and strategic changes on Nov 14, 2025.

Comments (0)

Newest

No comments yet.